首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   80783篇
  免费   6099篇
  国内免费   280篇
耳鼻咽喉   911篇
儿科学   2191篇
妇产科学   1096篇
基础医学   10884篇
口腔科学   909篇
临床医学   8551篇
内科学   17391篇
皮肤病学   922篇
神经病学   7768篇
特种医学   3387篇
外科学   12888篇
综合类   909篇
一般理论   91篇
预防医学   6018篇
眼科学   1980篇
药学   5452篇
  1篇
中国医学   95篇
肿瘤学   5718篇
  2024年   55篇
  2023年   670篇
  2022年   1042篇
  2021年   2424篇
  2020年   1366篇
  2019年   2217篇
  2018年   2550篇
  2017年   1818篇
  2016年   1914篇
  2015年   2243篇
  2014年   3234篇
  2013年   4108篇
  2012年   6519篇
  2011年   6761篇
  2010年   3730篇
  2009年   3313篇
  2008年   5409篇
  2007年   5628篇
  2006年   5215篇
  2005年   5164篇
  2004年   4654篇
  2003年   4272篇
  2002年   3870篇
  2001年   614篇
  2000年   416篇
  1999年   596篇
  1998年   887篇
  1997年   704篇
  1996年   589篇
  1995年   502篇
  1994年   481篇
  1993年   493篇
  1992年   267篇
  1991年   214篇
  1990年   196篇
  1989年   206篇
  1988年   195篇
  1987年   155篇
  1986年   164篇
  1985年   175篇
  1984年   198篇
  1983年   165篇
  1982年   255篇
  1981年   266篇
  1980年   184篇
  1979年   102篇
  1978年   122篇
  1977年   120篇
  1976年   88篇
  1975年   65篇
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
1.
2.
3.
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal...  相似文献   
4.
5.
Abstract

Objective

Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies.  相似文献   
6.
7.
8.
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology  相似文献   
9.
Arthroscopic acromioclavicular joint excision is a commonly performed but technically demanding procedure. Incomplete excision can leave residual symptoms. We present a simple, reproducible technique ensuring satisfactory excision of the joint.  相似文献   
10.
Coronavirus disease 2019 (COVID-19) has resulted in many challenges in patient care, especially among high-risk populations such as heart transplant recipients. Patients with heart transplant experience a significantly higher mortality rate with COVID-19 infection, and management is based on extrapolation from clinical trials done on nontransplant patients and from clinical experience. Here we report 4 cases of patients with heart transplant who presented with COVID-19 infection in late 2020. Patients presented with symptoms similar to those seen in the general population. All 4 patients were admitted to the hospital, and they were all treated with dexamethasone. In addition, 2 patients received remdesivir. Immunosuppressive medications were adjusted to maintain adequate levels of immunosuppression but at the same time allow for an adequate immune response against the infection. All patients were discharged alive from the hospital. We then performed a literature review on studies that included heart transplant patients who developed the infection and developed suggestions for a standardized management approach, which we share in this article.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号